Policy Notices

• Update - NIH Response to Registration Issues in SAM.gov
  (NOT-OD-23-153)
  National Institutes of Health
  

• Review Integrity and Bias Awareness Training will be Required for NIH Reviewers Effective May 2024 Council Round
  (NOT-OD-23-156)
  National Institutes of Health
  

General Notices

• Notice of NCCIH Technical Assistance Webinar and Teaming Webinar for RFA-AT-22-003 "HEAL Initiative: Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/R33, Clinical Trial Required)"
  (NOT-AT-24-010)
  National Center for Complementary and Integrative Health
  

• Notice of Prize Competition for the DataWorks! - NIH FASEB Challenge
  (NOT-OD-23-151)
  Office of the Director, NIH
  

• Request for Information (RFI): Inviting Input Regarding NIDCDs Research Directions to Support Communication in Minimally Verbal/Non-Speaking People
  (NOT-DC-23-013)
  National Institute on Deafness and Other Communication Disorders
  

• Request for Information (RFI): Infrastructure for Research in Nonhuman Primates
  (NOT-OD-23-150)
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  

• Request for Information (RFI) on Flexibilities for Streamlining IACUC Review of Protocols and Significant Changes
  (NOT-OD-23-152)
  Office of the Director, NIH
  

• Request for Information (RFI) on an Update to the Current OLAW Guidance Disclaimer
  (NOT-OD-23-157)
  Office of the Director, NIH
  

Notice of Changes to Funding Opportunities

• Notice of Correction to Award Budget in RFA-CA-23-027 "Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)"
  (NOT-CA-23-077)
  National Cancer Institute
  

• Notice of Change to the Composition of the Advisory Committee in PAR-23-063 "Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)"
  (NOT-GM-23-047)
  National Institute of General Medical Sciences
  

• Notice of Expiration of NOT-GM-22-009 Notice of Special Interest (NOSI): Administrative Supplements to Support Undergraduate Summer Research Experiences
  (NOT-GM-23-048)
  National Institute of General Medical Sciences
  

• Notice of Corrected Application Forms for RFA-HG-22-027, Diversity Centers for Genome Research (UG3/UH3 Clinical Trials Optional)
  (NOT-HG-23-046)
  National Human Genome Research Institute
  

• Notice of NINR Participation in PAR-23-166, Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)
  (NOT-NR-23-013)
  National Institute of Nursing Research
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for Approaches to Identifying Preteen Suicide Risk and Protective Factors (R01 Clinical Trial Not Allowed)
  (NOT-MH-23-335)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Coordinating Center for Approaches to Identifying Preteen Suicide Risk and Protective Factors (U24 Clinical Trial Not Allowed)
  (NOT-MH-23-336)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
  (NOT-NS-23-091)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

• Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
  (NOT-NS-23-093)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  

Notices of Special Interest

• Notice of Special Interest: Administrative Supplements for the U.S.-Japan Brain Research Cooperative Program (BRCP) - U.S. Entity (Admin Supp)
  (NOT-NS-23-092)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  

Funding Opportunities

• PHS 2023-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
  (PA-23-230)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Center for Environmental Health
  National Cancer Institute
  National Center for Injury Prevention and Control
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Institute for Occupational Safety and Health
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• PHS 2023-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
  (PA-23-231)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Center for Environmental Health
  National Cancer Institute
  National Center for Injury Prevention and Control
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Institute for Occupational Safety and Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
  (PA-23-232)
  National Institutes of Health
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• PHS 2023-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
  (PA-23-233)
  National Institutes of Health
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) - Transitional Centers (P30 Clinical Trial Optional)
  (PAR-23-216)
  National Institute of General Medical Sciences
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
  (PAR-23-219)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
  (PAR-23-220)
  Office of the Director, NIH
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Research Resource for Systematic Reviews of Complementary and Integrative Health (R24 Clinical Trial Not Allowed)
  (RFA-AT-24-005)
  National Center for Complementary and Integrative Health
  Application Receipt Date(s): August 31, 2023
  
  

• Limited Competition for the Continuation of Cure Glomerulonephropathy (CureGN) Participating Clinical Centers (U01 Clinical Trial Not Allowed)
  (RFA-DK-22-512)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 19, 2023
  
  

• Single Source for the Continuation of Cure Glomerulonephropathy (CureGN) Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-DK-22-513)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 19, 2023
  
  

• Single Source: NIH Blueprint for Neuroscience Research: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)
  (RFA-EB-23-007)
  National Institute of Biomedical Imaging and Bioengineering
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute of Dental and Craniofacial Research
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute of Neurological Disorders and Stroke
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 26, 2023
  
  

• Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Research Centers (U01 Clinical Trial Not Allowed)
  (RFA-HL-24-006)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 27, 2023
  
  

• Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Data Coordinating Center (U24- Clinical Trial Not Allowed)
  (RFA-HL-24-007)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 27, 2023
  
  

• Single Source: Molecular Atlas of Lung Development Program (LungMAP) Phase 3 - Human Tissue Core (U01- Clinical Trial Not Allowed)
  (RFA-HL-24-012)
  National Heart, Lung, and Blood Institute
  Application Receipt Date(s): October 27, 2023
  
  

• Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical High Risk for Psychosis Clinical Trial Network (U01 Clinical Trial Required)
  (RFA-MH-24-150)
  National Institute of Mental Health
  Application Receipt Date(s): October 17, 2023
  
  

• Single Source: Accelerating Medicines Partnership Schizophrenia (AMP SCZ): Clinical Trial Data Processing, Analysis, and Coordination Center (U24 Clinical Trial Not Allowed)
  (RFA-MH-24-151)
  National Institute of Mental Health
  Application Receipt Date(s): October 17, 2023
  
  

• Partnerships With Common Fund Data Ecosystem Resources (U24 Clinical Trial not Allowed)
  (RFA-RM-23-013)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): December 04, 2023